SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million

Reuters

Mar 21

SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million

SINTX published its annual report on Form 10-K, reporting total revenue of USD 1.02 million, down 65%.
Product revenue was USD 729,000, down 41%, and grant and contract revenue was USD 289,000, down 82%, with the revenue decline attributed mainly to a planned shift away from non-core, low-margin OEM technical manufacturing contracts.
Net loss was USD 10.36 million, narrowing 6%, while loss from operations was USD 10.72 million, narrowing 24%.
Research and development expense was USD 4.59 million, down 12%, and general and administrative expense was USD 6.2 million, up 55%.
Management said it began recognizing commercial revenue from OsseoSculpt in the second half of 2025 and expects revenue for its FDA 510(k)-cleared foot and ankle osteotomy wedge system to begin in the first half of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SINTX Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011924), on March 20, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2621754418"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2621754418\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2621754418?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-21 05:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621754418","market":"us","top_or_hot":-1,"title":"SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          SINTX published its annual report on Form 10-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>, reporting total revenue of USD 1.02 million, down 65%.\n        </li>\n<li>\n          Product revenue was USD 729,000, down 41%, and grant and contract revenue was USD 289,000, down 82%, with the revenue decline attributed mainly to a planned shift away from non-core, low-margin OEM technical manufacturing contracts.\n        </li>\n<li>\n          Net loss was USD 10.36 million, narrowing 6%, while loss from operations was USD 10.72 million, narrowing 24%.\n        </li>\n<li>\n          Research and development expense was USD 4.59 million, down 12%, and general and administrative expense was USD 6.2 million, up 55%.\n        </li>\n<li>\n          Management said it began recognizing commercial revenue from OsseoSculpt in the second half of 2025 and expects revenue for its FDA 510(k)-cleared foot and ankle osteotomy wedge system to begin in the first half of 2026.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/SINT\">SINTX Technologies Inc</a>. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011924), on March 20, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-21 05:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          SINTX published its annual report on Form 10-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>, reporting total revenue of USD 1.02 million, down 65%.\n        </li>\n<li>\n          Product revenue was USD 729,000, down 41%, and grant and contract revenue was USD 289,000, down 82%, with the revenue decline attributed mainly to a planned shift away from non-core, low-margin OEM technical manufacturing contracts.\n        </li>\n<li>\n          Net loss was USD 10.36 million, narrowing 6%, while loss from operations was USD 10.72 million, narrowing 24%.\n        </li>\n<li>\n          Research and development expense was USD 4.59 million, down 12%, and general and administrative expense was USD 6.2 million, up 55%.\n        </li>\n<li>\n          Management said it began recognizing commercial revenue from OsseoSculpt in the second half of 2025 and expects revenue for its FDA 510(k)-cleared foot and ankle osteotomy wedge system to begin in the first half of 2026.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/SINT\">SINTX Technologies Inc</a>. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011924), on March 20, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SINT","symbol_name":"SINTX Technologies Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL4bNZkx:1","article_id":"2621754418","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621754418","pubTimestamp":1774040524,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"SINTX published its annual report on Form 10-K, reporting total revenue of USD 1.02 million, down 65%.Product revenue was USD 729,000, down 41%, and grant and contract revenue was USD 289,000, down 82%, with the revenue decline attributed mainly to a planned shift away from non-core, low-margin OEM technical manufacturing contracts.Net loss was USD 10.36 million, narrowing 6%, while loss from operations was USD 10.72 million, narrowing 24%.Research and development expense was USD 4.59 million, down 12%, and general and administrative expense was USD 6.2 million, up 55%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SINTX Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Ga","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SINT":"SINTX Technologies Inc","BK4082":"医疗保健设备"},"translate_title":"SINTX Technologies 2025财年净亏损为1040万美元，总收入下降65%至102万美元","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SINT":0.9},"content_text":"SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million\n    \n\n\n          SINTX published its annual report on Form 10-K, reporting total revenue of USD 1.02 million, down 65%.\n        \n\n          Product revenue was USD 729,000, down 41%, and grant and contract revenue was USD 289,000, down 82%, with the revenue decline attributed mainly to a planned shift away from non-core, low-margin OEM technical manufacturing contracts.\n        \n\n          Net loss was USD 10.36 million, narrowing 6%, while loss from operations was USD 10.72 million, narrowing 24%.\n        \n\n          Research and development expense was USD 4.59 million, down 12%, and general and administrative expense was USD 6.2 million, up 55%.\n        \n\n          Management said it began recognizing commercial revenue from OsseoSculpt in the second half of 2025 and expects revenue for its FDA 510(k)-cleared foot and ankle osteotomy wedge system to begin in the first half of 2026.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SINTX Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011924), on March 20, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}